Company / FCF Margin
Caribou Biosciences, Inc. FCF Margin History
FY2021-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest FCF Margin
-1006.8%
FY2025
5-year range
-1006.8% / -304.3%
FY2021-FY2025
Trend
-230.9%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
FCF Margin changed -231% YoY in FY2025, a notable deviation from the 4-year average annual change of -58%.
Based on SEC 10-K filings.
-1006.8% in FY2025 with a 3-year CAGR of -645.9%.
Declined from -703.3% to -1006.8% over the past 2 years.
FCF Margin over time
Growth rates
- 3-Year Change
- -645.9pp
- 5-Year Change
- -
- 10-Year Change
- -
Key checks
Key Insights
- In FY2025, fcf margin decreased 230.9% year-over-year.
- Peak fcf margin was recorded in FY2024.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -3.99 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | FCF MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -1006.8% | -230.9% |
| FY2024 | -304.3% | +56.7% |
| FY2023 | -703.3% | -94.9% |
| FY2022 | -360.9% | +36.5% |
| FY2021 | -568.2% | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026